Navigation Links
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
Date:6/8/2008

tion of SB-509 in diabetics with moderate to severe diabetic peripheral sensory motor neuropathy in the legs. The trial is being conducted at multiple sites, accrual has been completed and plans recently announced to expand the study and enroll additional subjects.

In the initial trial, 45 subjects have completed enrollment. Subjects were randomized to one of two groups in a 2:1 ratio. The larger group (approximately 30 subjects) was treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into the lower limb and will be treated every 3 months. The remaining group (approximately 15 subjects) received an equal volume of placebo on the same schedule. Each subject will receive a total of two treatments (Day 0 and 90). Subjects receive injections in a distribution pattern that targets the major peripheral nerves in the legs and feet.

As announced on June 6, 2008, Sangamo will expand the Phase 2 study by enrolling approximately 45 additional subjects in the trial. Subjects will again be randomized to one of two groups in a 2:1 ratio. The larger group (approximately 30 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into the lower limb every 2 months. The remaining group (approximately 15 subjects) will receive an equal volume of placebo on the same schedule. Each subject will receive a total of three treatments (Day 0, 60 and 120). Subjects will receive injections in the same pattern used in the initial part of the trial.

The symptoms of diabetic peripheral neuropathy and any changes that occur during the trial will be evaluated based on neurological examination data, electrophysiological testing data, subject neurological questionnaire, and subject pain assessment. Specifically, investigators will assess pain using VASPI, and use scoring systems such as a modified NIS-LL and TNS to quantify neurologic exam and assess signs and symptoms of the condition.

For each subject
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
2. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
3. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
4. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
5. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
6. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
7. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
8. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
9. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
10. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
11. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Sept. 7, 2011 The Long Term Care Pharmacy ... Medicare D Residents in Skilled Nursing Facilities," has been ... Pharmacist, the official peer-reviewed journal of the American Society ... study to measure the quantity and the value of ...
... HEWA) a leading VIPPS accredited retail mail-order pharmacy, today ... will present at the Kaufman Brothers 14th Annual Investor ... Time on September 7, 2011. The public ... of the presentation on the Investor Relations section of ...
Cached Medicine Technology:LTCPA Study Quantifying Unused Medicare Part D Drugs in Skilled Nursing Facilities Published in The Consultant Pharmacist 2
(Date:8/31/2014)... 2014 This September, California Library ... Library, celebrates 30 years of changing the lives ... inception, California’s Library Literacy Services has helped nearly ... read and write. , To mark the 30th ... is launching a month-long awareness campaign titled “Together, ...
(Date:8/31/2014)... Spain Sunday 31 August 2014: Wine only protects ... to results from the In Vino Veritas (IVV) study ... from the Czech Republic. , Professor Taborsky said: "This ... red and white wine on markers of atherosclerosis (1) ... We found that moderate wine drinking was only protective ...
(Date:8/30/2014)... 31 August 2014: A retrievable and repositionable transcatheter ... real world setting, according to research presented at ... from Germany. The direct flow medical (DFM) transcatheter ... control and has the potential to improve transcatheter ... severe aortic stenosis. , Dr Pyxaras said: "TAVI ...
(Date:8/30/2014)... In a world where a typical response to conflict is ... a game app to teach another way. Launched in ... is a colorful way to encourage moral values playfully. ... double-duty by teaching players new ways to find happiness and ... for consistently taking the high road, the Ultimate Karma game ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 Recently, ... many web hosting companies and announced that BlueHost ... suppliers for webmasters who want to buy high ... we recommend are the best web host companies ... and server speed with top-level support.” A spokesman ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Wine only protects against CVD in people who exercise 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2
... team has discovered a new protein family that may play ... some forms of cancer and even heart disease. , The ... system are published in the March 7 edition of the ... the National Institutes of Health. , What we found is ...
... MS Awareness Week March,10 - 17 unites MS organizations ... nationwide in an effort to shine a spotlight on ... disease where someone is,newly diagnosed each hour., (Logo: ... Ways To Join The MS Movement, The ...
... Hib meningitis has been virtually eliminated in,young children ... introduced Haemophilus influenzae type,b (Hib) vaccine nationwide, according ... b is a leading cause of pneumonia and ... and spinal cord. Each year, Hib kills approximately ...
... the charge in adapting drug dosing to a society ... of obesity in the Western World continues to rise ... researchers face the ongoing challenge of determining just how ... compositions. , In a pharmacological sense, obesity presents ...
... Carell, Stephen, Colbert, Susie Essman, Will Ferrell, Tina Fey, Jonah Hill, Kevin ... Triumph The Insult Comic Dog And Many More To Be ... And xBox Live, Marketplace For $1.99 For 30 Days After Airdate With All ... ...
... Patient Care and Reduced Costs for Hospitals by ... Service Delivery with Significant ROI, DETROIT, March ... launched a new initiative to provide hospitals and,physicians ... dynamically,changing healthcare technology environment. By proactively managing service,delivery ...
Cached Medicine News:Health News:UCF researchers discover a new protein family implicated in inflammatory diseases 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 3Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 4Health News:Deadly disease eliminated in children under 5 years of age in Uganda 2Health News:Deadly disease eliminated in children under 5 years of age in Uganda 3Health News:Deadly disease eliminated in children under 5 years of age in Uganda 4Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 3Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 2Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 3
For use with catalog #0540, 0887....
For use with catalog #0540....
For use with catalog #0454....
Determination of FDP in Plasma by Latex Agglutination, 60 tests.Microlatex particles coated with mouse monoclonal anti-human FDP antibodies....
Medicine Products: